Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS)

CNY 31.24

(-1.26%)

Market Cap (In CNY)

14.29 Billion

Revenue (In CNY)

8.53 Billion

Net Income (In CNY)

643.38 Million

Avg. Volume

6.75 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
24.61-66.87
PE
-
EPS
-
Beta Value
0.687
ISIN
CNE100002VW1
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Yaoming Liang
Employee Count
-
Website
https://www.kingmed.com.cn
Ipo Date
2017-09-08
Details
Guangzhou Kingmed Diagnostics Group Co., Ltd. operates as a third-party medical laboratory company. The company offers medical diagnostic information, clinical trial, lab, food and hygiene testing, health management, medical cold chain logistics, and scientific research services, as well as vitro diagnostics, healthcare big data, artificial intelligence, and forensic testing services. It operates 37 testing laboratories in mainland of China and Hong Kong. The company was founded in 2003 and is headquartered in Guangzhou, China.